Is 18F-FDG PET a 'potentially hazardous' or an effective tool in evaluating patients with large-vessel vasculitis?

Clin Exp Rheumatol. 2013 Jan-Feb;31(1 Suppl 75):S93. Epub 2013 Feb 1.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antibodies, Monoclonal, Murine-Derived / therapeutic use*
  • Antirheumatic Agents / therapeutic use*
  • Cyclophosphamide / therapeutic use*
  • Humans
  • Systemic Vasculitis / drug therapy*

Substances

  • Antibodies, Monoclonal, Murine-Derived
  • Antirheumatic Agents
  • Cyclophosphamide